NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02728622,Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane,https://clinicaltrials.gov/study/NCT02728622,,COMPLETED,A randomized study of chemotherapy versus hormonal treatment in patients with ovarian cancer resistant or refractory to platinum and taxane.,NO,Ovarian Cancer|Peritoneal Cancer|Cancer of the Fallopian Tube,DRUG: Tamoxifen|DRUG: Chemotherapy,"Quality-adjusted survival, through completion of study, on average 1 year","progression-free survival, time to progressive disease or death, through completion of study, on average 3 months|overall survival, time to death of any cause, through completion of study, on average 1 year",,Nordic Society of Gynaecological Oncology - Clinical Trials Unit,,FEMALE,"ADULT, OLDER_ADULT",PHASE3,241,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,NSGO-OC-0101,2002-03,2008-01,2009-01,2016-04-05,,2016-04-05,,
